US Patent Issued to Invirsa on July 29 for "Methods for the use of 5'-adenosine diphosphate ribose (ADPR)" (Ohio Inventor)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,370,209, issued on July 29, was assigned to Invirsa Inc. (Columbus, Ohio).

"Methods for the use of 5'-adenosine diphosphate ribose (ADPR)" was invented by Robert Shalwitz (Bexley, Ohio).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to methods for the use of 5'-adenosine diphosphate ribose (ADPR), and compositions thereof, for treating, managing, or preventing adenovirus-related diseases or conditions, eye disorders, cancer, or diseases or conditions caused by infection, inflammation, or physical, chemical, thermal, or radiation injuries."

The patent was filed on Nov. 7, 2023, under Application No. 18/503,967.

*For fur...